Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Sturm

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 26, 2016
Treatment satisfaction, preferences and perception gaps between patients and physicians in the ulcerative colitis CARES study: A real world-based studyLaurent Peyrin-Biroulet, Gert Van Assche, Andreas Sturm, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 4, 2016
Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months - Multicenter European cohort studyGert Van Assche, Laurent Peyrin-Biroulet, Andreas Sturm, et al.
Zeitschrift Fur Gastroenterologie|August 7, 2024
Andreas Sturm, Raja Atreya, Dominik Bettenworth, et al.
Inflammatory Bowel Diseases|December 20, 2007
No association of the CARD8 (TUCAN) c.30T>A (p.C10X) variant with Crohn's disease: a study in 3 independent European cohortsCarsten Büning, Hartmut H-J Schmidt, Tamás Molnár, et al.
Zeitschrift Fur Gastroenterologie|March 9, 2022
Andreas Sturm, Raja Atreya, Dominik Bettenworth, et al.
Journal of Crohn'S & Colitis|December 22, 2010
A study in three European IBD cohorts confirms that the ATG16L1 c.898A>G (p.Thr300Ala) variant is a susceptibility factor for Crohn's diseaseCarsten Büning, Tahir Durmus, Tamas Molnar, et al.
Deutsches Arzteblatt International|September 24, 2016
Fecal Microbiota Transplant in Patients With Recurrent Clostridium Difficile InfectionStefan Hagel, Anne Fischer, Philipp Ehlermann, et al.
Digestive Diseases and Sciences|June 11, 2009
Significant differences between Crohn's disease and ulcerative colitis regarding the impact of body mass index and initial disease activity on responsiveness to azathioprine: results from a European multicenter study in 1,176 patientsMartin H Holtmann, Frank Krummenauer, Christina Claas, et al.
Digestive Diseases and Sciences|August 24, 2006
Long-term effectiveness of azathioprine in IBD beyond 4 years: a European multicenter study in 1176 patientsMartin H Holtmann, Frank Krummenauer, Christina Claas, et al.
Gastroenterology|February 9, 2013
Increased T-helper 2 cytokines in bile from patients with IgG4-related cholangitis disrupt the tight junction-associated biliary epithelial cell barrierTobias Müller, Claudia Beutler, Almudena Hurtado Picó, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 26, 2016
Treatment satisfaction, preferences and perception gaps between patients and physicians in the ulcerative colitis CARES study: A real world-based studyLaurent Peyrin-Biroulet, Gert Van Assche, Andreas Sturm, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 4, 2016
Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months - Multicenter European cohort studyGert Van Assche, Laurent Peyrin-Biroulet, Andreas Sturm, et al.
Zeitschrift Fur Gastroenterologie|August 7, 2024
Andreas Sturm, Raja Atreya, Dominik Bettenworth, et al.
Inflammatory Bowel Diseases|December 20, 2007
No association of the CARD8 (TUCAN) c.30T>A (p.C10X) variant with Crohn's disease: a study in 3 independent European cohortsCarsten Büning, Hartmut H-J Schmidt, Tamás Molnár, et al.
Zeitschrift Fur Gastroenterologie|March 9, 2022
Andreas Sturm, Raja Atreya, Dominik Bettenworth, et al.
Journal of Crohn'S & Colitis|December 22, 2010
A study in three European IBD cohorts confirms that the ATG16L1 c.898A>G (p.Thr300Ala) variant is a susceptibility factor for Crohn's diseaseCarsten Büning, Tahir Durmus, Tamas Molnar, et al.
Deutsches Arzteblatt International|September 24, 2016
Fecal Microbiota Transplant in Patients With Recurrent Clostridium Difficile InfectionStefan Hagel, Anne Fischer, Philipp Ehlermann, et al.
Digestive Diseases and Sciences|June 11, 2009
Significant differences between Crohn's disease and ulcerative colitis regarding the impact of body mass index and initial disease activity on responsiveness to azathioprine: results from a European multicenter study in 1,176 patientsMartin H Holtmann, Frank Krummenauer, Christina Claas, et al.
Digestive Diseases and Sciences|August 24, 2006
Long-term effectiveness of azathioprine in IBD beyond 4 years: a European multicenter study in 1176 patientsMartin H Holtmann, Frank Krummenauer, Christina Claas, et al.
Gastroenterology|February 9, 2013
Increased T-helper 2 cytokines in bile from patients with IgG4-related cholangitis disrupt the tight junction-associated biliary epithelial cell barrierTobias Müller, Claudia Beutler, Almudena Hurtado Picó, et al.
Pageof 11